Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging
NCT: NCT04400292 · ACTIVE_NOT_RECRUITING
Brief Summary
The purpose of this study is to find out whether sentinel lymph node (SLN) mapping with ICG dye and NIR imaging can be used to identify esophageal or esophagogastric junction cancer that has spread to the lymph nodes. If SLN mapping is successful in these types of cancer, surgeons in the future could identify the sentinel lymph nodes and only remove these instead of removing all the lymph nodes which is currently done.
Frequently Asked Questions
What is Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging?
Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging is a clinical trial registered under NCT04400292. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04400292?
The current status of NCT04400292 (Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging) is: ACTIVE_NOT_RECRUITING.
When did Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging start?
Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging started on 2020-05-20.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.